Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Dystrophin ELISA Kit (AC3016)
Cat.#: ASET-1605
Specifications
Description Mouse Dystrophin ELISA Kit allows for the in vitro quantitative determination of mouse Dystrophin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1184 Rat Somatostatin ELISA Kit (AC2595) Quantitative inquiry ASET-1925 Human MERTK ELISA Kit (AC3336) Quantitative inquiry ASET-1032 Human TrkC ELISA Kit (AC2443) Quantitative inquiry ASET-1381 Chicken Neurotrophin 3 ELISA Kit (AC2792) Quantitative inquiry ASET-1428 Sheep Myelin Basic Protein ELISA Kit (AC2839) Quantitative inquiry ASET-1591 Mouse IL-6 ELISA Kit (AC3002) Quantitative inquiry ASET-2272 Mouse SNAP25 ELISA Kit (AC3683) Quantitative inquiry ASET-1973 Rat Gli2 ELISA Kit (AC3384) Quantitative inquiry ASET-2507 Sheep Antidiuretic Hormone ELISA Kit (AC3918) Quantitative inquiry ASET-2309 Human NECL-1 ELISA Kit (AC3720) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket